Results
1 -
10 of
121UD-CG 115 u2014 a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle, Naunyn-Schmiedeberg's Archives of Pharmacology Selective blockade of nicotinic acetylcholine receptors by pimobendan, a drug for the treatment of heart failure: reduction of catecholamine secretion and synthesis in adrenal medullary cells, Naunyn-Schmiedeberg's Archives of Pharmacology Mechanism of Action of Ca2+ Sensitizersu2014Update 2001, Cardiovascular Drugs and Therapy EMD 53998 acts as Ca2+-sensitizer and phosphodiesterase III-inhibitor in human myocardium, Basic Research in Cardiology E-1020, a water soluble imidazopyridine, has direct effects on Ca2+-dependent force and ATP hydrolysis of canine and bovine cardiac myofilaments, Biochemical Mechanisms in Heart Function Sympathomimetic vs Non-Sympathomimetic Drugs in the Treatment of Heart Failure, Clinical Aspects of O2 Transport and Tissue Oxygenation Introduction: Mechanisms of positive inotropic effects, Inotropic Stimulation and Myocardial Energetics Introduction: Mechanisms of positive inotropic effects, Basic Research in Cardiology Effects of Different Positive Inotropic Drugs in Congestive Heart Failure, Heart Failure Mechanisms and Management Pimobendan: a new approach to heart failure, InPharma